6 Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
PubMed laboratory research record [PMID: 40511027] PubMed record related to this compound for laboratory literature review
MPNST with heterologous rhabdomyoblastic differentiation
Throughout the study, weight loss was gradual, with no plateau observed at 13 weeks, and the drug was found to be safe and well-tolerated (see Figure 1)
TB-500 has anchored decades of cytoskeletal and endothelial migration research since the original characterisation of thymosin beta-4 in the 1980s and the landmark integrin-linked kinase work by Bock-Marquette and colleagues (Nature, 2004)
131 LindnAUvns-MobergKForsbergGBednarISderstenP